CliffBio

Antares Pharma Inc.

Patent cliffs & loss of exclusivity

Parenteral drugs and Injectors

Company

CAGE Code8BD12
Legal NameAntares Pharma, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.antarespharma.com/contact-us
Crunchbase URLhttps://www.crunchbase.com/organization/antares-pharma
Full Address100 PRINCETON S STE 300 EWING, NJ 08628 UNITED STATES
LinkedIn URLhttp://www.linkedin.com/company/antares-pharma-inc-
Pitchbook URLhttps://pitchbook.com/profiles/company/41941-72#overview

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. XYOSTED (AUTOINJECTOR)TESTOSTERONE ENANTHATESmall mol.Sep 2036
  2. XYOSTED (AUTOINJECTOR)TESTOSTERONE ENANTHATESmall mol.Sep 2036
  3. XYOSTED (AUTOINJECTOR)TESTOSTERONE ENANTHATESmall mol.Sep 2036
  4. SUMATRIPTAN SUCCINATE (AUTOINJECTOR)SUMATRIPTAN SUCCINATESmall mol.—
  5. SUMATRIPTAN SUCCINATE (AUTOINJECTOR)SUMATRIPTAN SUCCINATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.